Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung CancerNew England Journal of MedicineOctober 9, 201610.1056/nejmoa1606774Cited by 10,101SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis